Supports Safe Access to Medication Abortion
Official: Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
This resolution expresses the House of Representatives' support for recognizing the safety and effectiveness of mifepristone and advocates for fair access to medication abortion care.
1. This resolution emphasizes the importance of over 25 years of studies showing mifepristone's safety and effectiveness. 2. It calls for laws and policies on medication abortion to be fair and based on scientific evidence. 3. The resolution aims to ensure that access to this type of abortion care is transparent and equitable. 4. It reflects the views of the House of Representatives on the need for evidence-based healthcare policies.
This resolution affects individuals seeking medication abortion care and healthcare providers involved in reproductive health.